Related Experiment Video

Updated: Aug 13, 2026

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
08:23

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

Anesthetic management in two siblings with glutaric aciduria type 1

Joaquín Hernández-Palazón1, Lorenzo Sánchez-Ródenas, Juan F Martínez-Lage

  • 1Staff Anaesthesiologist, Department of Anaesthesia, H.U. Virgen de la Arrixaca, Murcia, Spain. joapal@ono.com

Paediatric Anaesthesia
|January 25, 2006
PubMed

Insights

Glutaric aciduria type 1 (GA-1), a metabolic disorder, can cause neurological issues. Anesthetic management using propofol and remifentanil was successfully employed for two young GA-1 patients undergoing CSF shunting.

Area of Science:

  • Biochemistry
  • Pediatric Neurology
  • Anesthesiology

Background:

  • Glutaric aciduria type 1 (GA-1) is an inherited metabolic disorder caused by glutaryl-CoA dehydrogenase deficiency.
  • It typically presents in early childhood, often leading to a dystonic-dyskinetic syndrome and neurological complications.

Observation:

  • Two sisters with GA-1, aged 30 and 17 months, exhibited macrocephaly and psychomotor delay.
  • Both patients required cerebrospinal fluid (CSF) shunting due to hydrocephalus and subdural fluid collections.

Findings:

  • The anesthetic management for these procedures involved total intravenous anesthesia (TIVA).
  • Propofol and remifentanil were utilized as the primary anesthetic agents.

Implications:

  • This case report highlights successful anesthetic strategies for pediatric patients with GA-1 undergoing neurosurgery.
  • It suggests TIVA with propofol and remifentanil is a viable option for managing GA-1 patients requiring CSF shunting.
  • Further research into anesthetic considerations for rare metabolic disorders like GA-1 is warranted.

More Related Videos

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...